The role of radical prostatectomy for the treatment of metastatic prostate cancer: a systematic review and meta-analysis
暂无分享,去创建一个
Zhiqiang Qin | Chen Chen | Z. Qin | N. Song | Yi Wang | Yamin Wang | Yichun Wang | Xianghu Meng | Ninghong Song | Yi Wang | Xianghu Meng | Yichun Wang | Chen Chen | Ya-min Wang | Zhiqiang Qin
[1] C. Bach,et al. Radical prostatectomy for locally advanced and metastatic prostate cancer , 2017, Annals of the Royal College of Surgeons of England.
[2] C. Stief,et al. Role of radical prostatectomy in metastatic prostate cancer: data from the Munich Cancer Registry. , 2014, European urology.
[3] P. Scardino. Update: NCCN prostate cancer Clinical Practice Guidelines. , 2005, Journal of the National Comprehensive Cancer Network : JNCCN.
[4] Ituro Inoue,et al. Meta-analysis of genetic association studies: methodologies, between-study heterogeneity and winner's curse , 2009, Journal of Human Genetics.
[5] W. Shih,et al. Cancer-specific survival after metastasis following primary radical prostatectomy compared with radiation therapy in prostate cancer patients: results of a population-based, propensity score-matched analysis. , 2014, European urology.
[6] M. Menon,et al. Identifying optimal candidates for local treatment of the primary tumor among patients diagnosed with metastatic prostate cancer: a SEER-based study. , 2015, European urology.
[7] L. Rangel,et al. Treatment of M1a/M1b prostate cancer with or without radical prostatectomy at diagnosis , 2017, Prostate Cancer and Prostatic Diseases.
[8] T. H. van der Kwast,et al. [EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer]. , 2011, Actas urologicas espanolas.
[9] M. Menon,et al. The Impact of Local Treatment on Overall Survival in Patients with Metastatic Prostate Cancer on Diagnosis: A National Cancer Data Base Analysis. , 2017, European urology.
[10] J. Mohler. Concept and viability of androgen annihilation for advanced prostate cancer , 2014, Cancer.
[11] Michel Bolla,et al. [EAU guidelines on prostate cancer]. , 2009, Actas urologicas espanolas.
[12] P. Schellhammer,et al. Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study. , 2014, European urology.
[13] Paula R Williamson,et al. Aggregate data meta‐analysis with time‐to‐event outcomes , 2002, Statistics in medicine.
[14] R. Kaplan,et al. Bone marrow cells in the ‘pre-metastatic niche’: within bone and beyond , 2007, Cancer and Metastasis Reviews.
[15] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[16] D. Pfister,et al. Cytoreductive radical prostatectomy in patients with prostate cancer and low volume skeletal metastases: results of a feasibility and case-control study. , 2015, The Journal of urology.
[17] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[18] T. H. van der Kwast,et al. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. , 2011, European urology.
[19] Z. Hall. Cancer , 1906, The Hospital.
[20] A. Jemal,et al. Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.
[21] M. Stern,et al. Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis. , 2015, The Journal of urology.
[22] G. Guimarães,et al. Radical prostatectomy in metastatic prostate cancer: is there enough evidence? | Opinion: Yes , 2016, International braz j urol : official journal of the Brazilian Society of Urology.
[23] M. Bookman. Optimal primary therapy of ovarian cancer. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.
[24] Larry Norton,et al. Tumor Self-Seeding by Circulating Cancer Cells , 2009, Cell.
[25] G. Franck. Open access , 2012, Cell cycle.
[26] E. Crawford,et al. Metastatic prostate cancer-does treatment of the primary tumor matter? , 2006, The Journal of urology.
[27] Jun Ma,et al. Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein–Barr virus DNA level and tumor response to palliative chemotherapy , 2019, BMC Cancer.
[28] F. Montorsi,et al. A Multi-institutional Analysis of Perioperative Outcomes in 106 Men Who Underwent Radical Prostatectomy for Distant Metastatic Prostate Cancer at Presentation. , 2016, European urology.
[29] B. Ristau,et al. Radical prostatectomy in metastatic prostate cancer: is there enough evidence? | Opinion: No , 2016, International braz j urol : official journal of the Brazilian Society of Urology.
[30] Ronald C. Chen,et al. Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] C. Tangen,et al. Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis. , 2005, The Journal of urology.
[32] A. Stenzl,et al. Radical prostatectomy in advanced-stage and -grade disease: cure, cytoreduction, or cosmetics? , 2008, European urology.
[33] E. Castellón,et al. Surgical cytoreduction of the primary tumor reduces metastatic progression in a mouse model of prostate cancer , 2015, Oncology reports.
[34] K. Bensalah,et al. Cytoreductive radical prostatectomy in metastatic prostate cancer: Does it really make sense? , 2016, World Journal of Urology.
[35] Z. Qin,et al. Comparison between transrectal and transperineal prostate biopsy for detection of prostate cancer: a meta-analysis and trial sequential analysis , 2017, Oncotarget.
[36] A. Stang. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses , 2010, European Journal of Epidemiology.
[37] M. Menon,et al. Local Therapy Improves Survival in Metastatic Prostate Cancer. , 2017, European Urology.
[38] M. Sydes,et al. Practical methods for incorporating summary time-to-event data into meta-analysis , 2007, Trials.
[39] S. Antwi,et al. Prognostic impact of definitive local therapy of the primary tumor in men with metastatic prostate cancer at diagnosis: A population-based, propensity score analysis. , 2014, Cancer epidemiology.
[40] Rebecca L. Siegel Mph,et al. Cancer statistics, 2016 , 2016 .